AAAAAA
Results:
1-12
|
Results: 12
Authors:
Bos, M
Sleight, AJ
Godel, T
Martin, JR
Riemer, C
Stadler, H
Citation: M. Bos et al., 5-HT6 receptor antagonists: lead optimisation and biological evaluation ofN-aryl and N-heteroaryl 4-amino-benzene sulfonamides, EUR J MED C, 36(2), 2001, pp. 165-178
Authors:
Malherbe, P
Knoflach, F
Broger, C
Ohresser, S
Kratzeisen, C
Adam, G
Stadler, H
Kemp, JA
Mutel, V
Citation: P. Malherbe et al., Identification of essential residues involved in the glutamate binding pocket of the group II metabotropic glutamate receptor, MOLEC PHARM, 60(5), 2001, pp. 944-954
Authors:
Kaspar, M
Stadler, H
Weiss, T
Ziegler, C
Citation: M. Kaspar et al., Thickness shear mode resonators ("mass-sensitive devices") in bioanalysis, FRESEN J AN, 366(6-7), 2000, pp. 602-610
Authors:
Ketterer, T
Stadler, H
Rickert, J
Bayer, E
Gopel, W
Citation: T. Ketterer et al., Detection of oligonucleotide sequences with quartz crystal oscillators, SENS ACTU-B, 65(1-3), 2000, pp. 73-75
Authors:
Schweitzer, C
Kratzeisen, C
Adam, G
Lundstrom, K
Malherbe, P
Ohresser, S
Stadler, H
Wichmann, J
Woltering, T
Mutel, V
Citation: C. Schweitzer et al., Characterization of [H-3]-LY354740 binding to rat mGlu2 and mGlu3 receptors expressed in CHO cells using Semliki Forest virus vectors, NEUROPHARM, 39(10), 2000, pp. 1700-1706
Authors:
Stadler, H
Wichmann, J
Sleight, AJ
Bos, M
Citation: H. Stadler et al., Structure-activity relationships of substituted 2,3,4,4a,5,10b-hexahydro-benz[h]isoquinoline-6(1H)-ones as 5-HT2C receptor antagonists, CHIMIA, 54(11), 2000, pp. 669-671
Authors:
Jenck, F
Moreau, JL
Wichmann, J
Stadler, H
Martin, JR
Bos, M
Citation: F. Jenck et al., Brain 5-HT2C receptors: Potential role in anxiety disorders, MIL DRUG TH, 2000, pp. 119-137
Authors:
Oefner, C
Binggeli, A
Breu, V
Bur, D
Clozel, JP
D'Arcy, A
Dorn, A
Fischli, W
Gruninger, F
Guller, R
Hirth, G
Marki, HP
Mathews, S
Muller, M
Ridley, RG
Stadler, H
Vieira, E
Wilhelm, M
Winkler, FK
Wostl, W
Citation: C. Oefner et al., Renin inhibition by substituted piperidines: a novel paradigm for the inhibition of monomeric aspartic proteinases?, CHEM BIOL, 6(3), 1999, pp. 127-131
Authors:
Kolczewski, S
Adam, G
Stadler, H
Mutel, V
Wichmann, J
Woltering, T
Citation: S. Kolczewski et al., Synthesis of heterocyclic enol ethers and their use as group 2 metabotropic glutamate receptor antagonists, BIOORG MED, 9(15), 1999, pp. 2173-2176
Authors:
Vieira, E
Binggeli, A
Breu, V
Bur, D
Fischli, W
Guller, R
Hirth, G
Marki, HP
Muller, M
Oefner, C
Scalone, M
Stadler, H
Wilhelm, M
Wostl, W
Citation: E. Vieira et al., Substituted piperidines - Highly potent renin inhibitors due to induced fit adaptation of the active site, BIOORG MED, 9(10), 1999, pp. 1397-1402
Authors:
Guller, R
Binggeli, A
Breu, V
Bur, D
Fischli, W
Hirth, G
Jenny, C
Kansy, M
Montavon, F
Muller, M
Oefner, C
Stadler, H
Vieira, E
Wilhelm, M
Wostl, W
Marki, HP
Citation: R. Guller et al., Piperidine-renin inhibitors compounds with improved physicochemical properties, BIOORG MED, 9(10), 1999, pp. 1403-1408
Authors:
Stadler, H
Bos, M
Citation: H. Stadler et M. Bos, Highly enantioselective synthesis of 3-hydroxy-2-phenylpiperidine via the sharpless AD-reaction, HETEROCYCLE, 51(5), 1999, pp. 1067-1071
Risultati:
1-12
|